Ya-Chi Liu

Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development

C. Lai, Yunching Chen, Dong-Yu Gao, 2018, Theranostics.

Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.

Yunching Chen, Dong-Yu Gao, D. Wan, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors

R. Jain, K. Flaherty, C. Benes, 2017, Scientific Reports.

Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis.

Yunching Chen, F. Hsu, Jia-yu Liu, 2016, Molecular pharmaceutics.